InMed Pharmaceuticals (INM)
NASDAQ:INM
Holding INM?
Track your performance easily

InMed Pharmaceuticals (INM) Cash flow

324 Followers

InMed Pharmaceuticals Cash Flow

INM's free cash flow for Q4 2024 was $―. For the 2024 fiscal year, INM's free cash flow was decreased by $0.00 and operating cash flow was $-1.03M. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 24Jun 23Jun 22Jun 21Jun 16
Operating Cash Flow
$ -6.99M$ -6.99M$ -7.28M$ -15.58M$ -9.79M$ -386.07K
Investing Cash Flow
$ -9.29K$ -9.29K$ -661.80K$ -673.00K$ -1.73K$ -885.00
Financing Cash Flow
$ 4.65M$ 4.65M$ 10.68M$ 15.07M$ 10.85M$ 300.14K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 30.45M$ 6.57M$ 8.91M$ 6.18M$ 7.36M$ 41.92K
Income Tax Paid Supplemental Data
$ 7.10K$ 7.10K$ 13.10K---
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 4.65M$ 4.65M$ 10.68M$ 17.15M$ 12.47M$ 304.68K
Issuance Of Debt
---$ -290.83K--
Repayment Of Debt
---$ -290.83K--
Free Cash Flow
---$ -15.62M$ -9.79M$ -386.96K
Domestic Sales
------
Foreign Sales
------
Currency in USD

InMed Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis